379 Epi-RTM P2 Protocol Produces a Scalable Polyclonal TIL Product with a Greater Expansion Success Rate Across Hot and Cold Tumors in Shorter Culture Time
Journal for ImmunoTherapy of Cancer(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal for ImmunoTherapy of Cancer(2023)